ReviewFoods (Basel, Switzerland)2026
Edible Mushroom Polysaccharides as Functional Food Ingredients for Metabolic Health: Preparation, Techno-Functional Behavior, and Requirements for Translation.
Review in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Edible mushroom polysaccharide (EMP) preparations have repeatedly improved glycemic control, adiposity, lipid homeostasis and hepatic lipid accumulation in animal models, and luminal assays and microbiota-perturbation experiments support the routes involved. Selected preparations also thicken, emulsify, retain water and modify food matrices. Yet these findings rarely concern the same material: metabolic, mechanistic and techno-functional studies usually examine different preparations, and retained function is seldom assessed after formulation, processing and digestion. This narrative review uses preparation identity, defined by biological source, processing route and resulting material characteristics, to integrate preparation chemistry, gastrointestinal mechanisms, animal and human outcomes, food-system behavior and food-use considerations. Molecular size, solubility, hydration, binding and fermentability provide a shared physicochemical basis for food-matrix performance and gastrointestinal interactions. Animal doses, human intakes and food-matrix loadings overlap at gram scale, which leaves functional delivery as the unresolved step. Controlled human trials are still few, small and dissimilar in design, so translation remains to be tested. The central question is therefore whether a reproducible EMP preparation can retain its intended function in an acceptable food and produce matched human outcomes. Progress depends on following the same characterized preparation from production and food incorporation through processing, consumption and human evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.